References:
1. Depalo D. True Covid-19 mortality rates from administrative data.
Journal of population economics. 2021;34(1):253-74.
2. Rao C. Medical certification of cause of death for COVID-19. Bulletin
of the World Health Organization. 2020;98(5):298.
3. Nasri E, Shoaei P, Vakili B, Mirhendi H, Sadeghi S, Hajiahmadi S, et
al. Fatal invasive pulmonary aspergillosis in COVID-19 patient with
acute myeloid leukemia in Iran. Mycopathologia. 2020;185(6):1077-84.
4. Klok F, Kruip M, Van der Meer N, Arbous M, Gommers D, Kant K, et al.
Incidence of thrombotic complications in critically ill ICU patients
with COVID-19. Thrombosis research. 2020.
5. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian
T, et al. Venous and arterial thromboembolic complications in COVID-19
patients admitted to an academic hospital in Milan, Italy. Thrombosis
research. 2020.
6. Thomas W, Varley J, Johnston A, Symington E, Robinson M, Sheares K,
et al. Thrombotic complications of patients admitted to intensive care
with COVID-19 at a teaching hospital in the United Kingdom. Thrombosis
Research. 2020;191:76-7.
7. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M,
Delabranche X, et al. High risk of thrombosis in patients with severe
SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive
care medicine. 2020:1-10.
8. Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S,
et al. Management of thrombotic complications in COVID-19: an update.
Drugs. 2020:1-10.
9. Fontana P, Casini A, Robert-Ebadi H, Glauser F, Righini M, Blondon M.
Venous thromboembolism in COVID-19: systematic review of reported risks
and current guidelines. Swiss Medical Weekly. 2020;150(2526).
10. Wu T, Zuo Z, Yang D, Luo X, Jiang L, Xia Z, et al. Venous
thromboembolic events in patients with COVID-19: a systematic review and
meta-analysis. Age and ageing. 2020.
11. Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Deep vein
thrombosis: update on diagnosis and management. Medical Journal of
Australia. 2019;210(11):516-24.
12. Nagamalesh U, Prakash V, Naidu KK, Sarthak S, Hegde AV, Abhinay T.
Acute pulmonary thromboembolism: Epidemiology, predictors, and long-term
outcome–A single center experience. Indian heart journal.
2017;69(2):160-4.
13. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous
thromboembolism in patients with severe novel coronavirus pneumonia.
Journal of Thrombosis and Haemostasis. 2020.
14. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW.
Cardiovascular risk factors and venous thromboembolism. Circulation.
2008;117(1):93-102.
15. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical
characteristics of coronavirus disease 2019 in China. New England
journal of medicine. 2020;382(18):1708-20.
16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
characteristics of 138 hospitalized patients with 2019 novel
coronavirus–infected pneumonia in Wuhan, China. Jama.
2020;323(11):1061-9.
17. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and
risk factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: a retrospective cohort study. The lancet. 2020.
18. Santoliquido A, Porfidia A, Nesci A, De Matteis G, Marrone G,
Porceddu E, et al. Incidence of deep vein thrombosis among non‐ICU
patients hospitalized for COVID‐19 despite pharmacological
thromboprophylaxis. Journal of Thrombosis and Haemostasis.
2020;18(9):2358-63.
19. Can C, Topacoglu H, Ucku R. Investigation of relationship between
blood hemoglobin level and acute pulmonary embolism in emergency
setting. International Medical Journal. 2013;20(5):584.
20. Irace C, Scarinci F, Scorcia V, Bruzzichessi D, Fiorentino R,
Randazzo G, et al. Association among low whole blood viscosity,
haematocrit, haemoglobin and diabetic retinopathy in subjects with type
2 diabetes. British Journal of Ophthalmology. 2011;95(1):94-8.
21. Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray
M, et al. High incidence of venous thromboembolic events in
anticoagulated severe COVID‐19 patients. Journal of Thrombosis and
Haemostasis. 2020;18(7):1743-6.
22. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P,
Sebastian T, et al. Venous and arterial thromboembolic complications in
COVID-19 patients admitted to an academic hospital in Milan, Italy.
Thrombosis research. 2020;191:9-14.
23. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M,
Delabranche X, et al. High risk of thrombosis in patients with severe
SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive
care medicine. 2020;46(6):1089-98.
24. Huang Y-L, Hu Z-D. Lower mean corpuscular hemoglobin concentration
is associated with poorer outcomes in intensive care unit admitted
patients with acute myocardial infarction. Annals of translational
medicine. 2016;4(10).
25. Kalra PR, Greenlaw N, Ferrari R, Ford I, Tardif J-C, Tendera M, et
al. Hemoglobin and change in hemoglobin status predict mortality,
cardiovascular events, and bleeding in stable coronary artery disease.
The American journal of medicine. 2017;130(6):720-30.
26. Jimenez D, Escobar C, Marti D, Diaz G, Cesar J, Garcia-Avello A, et
al. Association of anaemia and mortality in patients with acute
pulmonary embolism. Thrombosis and haemostasis. 2009;102(07):153-8.
27. Khan MF, Shamael I, Zaman Q, Mahmood A, Siddiqui M. Association of
anemia with stroke severity in acute ischemic stroke patients. Cureus.
2018;10(6).
28. Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, et
al. Influence of baseline anemia on long-term clinical outcomes in
patients with venous thromboembolism: from the COMMAND VTE registry.
Journal of thrombosis and thrombolysis. 2019;47(3):444-53.
29. Harringa JB, Bracken RL, Nagle SK, Schiebler ML, Patterson BW,
Svenson JE, et al. Anemia is not a risk factor for developing pulmonary
embolism. The American journal of emergency medicine. 2017;35(1):146-9.
30. Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors
associated with acute respiratory distress syndrome and death in
patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA
internal medicine. 2020.
31. Helms J, Severac F, Merdji H, Anglés-Cano E, Meziani F.
Prothrombotic phenotype in COVID-19 severe patients. Intensive Care
Medicine. 2020:1.
32. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al.
ISTH interim guidance on recognition and management of coagulopathy in
COVID‐19. Journal of Thrombosis and Haemostasis. 2020;18(5):1023-6.
33. Zhang D-P, Mao X-F, Wu T-T, Chen Y, Hou X-G, Yang Y, et al. The
Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With
Coronary Artery Disease Who Underwent Percutaneous Coronary
Intervention. Clinical and Applied Thrombosis/Hemostasis.
2020;26:1076029620933008.
34. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Chadban SJ, Usherwood T,
et al. Chronic kidney disease and measurement of albuminuria or
proteinuria: a position statement. Medical Journal of Australia.
2012;197(4):224-5.
35. Folsom AR, Lutsey PL, Heckbert SR, Cushman M. Serum albumin and risk
of venous thromboembolism. Thrombosis and haemostasis. 2010;104(1):100.
36. Omar HR, Mirsaeidi M, Rashad R, Hassaballa H, Enten G, Helal E, et
al. Association of serum albumin and severity of pulmonary embolism.
Medicina. 2020;56(1):26.
37. Tian M, Li Y, Wang X, Tian X, Pei L-l, Wang X, et al. The
Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score Is Associated
With Poor Outcome of Acute Ischemic Stroke. Frontiers in Neurology.
2021;11:1713.
38. Kunutsor SK, Seidu S, Katechia DT, Laukkanen JA. Inverse association
between serum albumin and future risk of venous thromboembolism:
interrelationship with high sensitivity C-reactive protein. Annals of
medicine. 2018;50(3):240-8.
39. Wada H, Dohi T, Miyauchi K, Shitara J, Endo H, Doi S, et al.
Long-term clinical impact of serum albumin in coronary artery disease
patients with preserved renal function. Nutrition, Metabolism and
Cardiovascular Diseases. 2018;28(3):285-90.
40. Mirsaeidi M, Omar HR, Sweiss N. Hypoalbuminemia is related to
inflammation rather than malnutrition in sarcoidosis. European journal
of internal medicine. 2018;53:e14-e6.
41. Lam FW, Cruz MA, Leung H-CE, Parikh KS, Smith CW, Rumbaut RE.
Histone induced platelet aggregation is inhibited by normal albumin.
Thrombosis research. 2013;132(1):69-76.
42. Klok F, Kruip M, Van der Meer N, Arbous M, Gommers D, Kant K, et al.
Incidence of thrombotic complications in critically ill ICU patients
with COVID-19. Thrombosis research. 2020;191:145-7.
43. Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention
should be paid to venous thromboembolism prophylaxis in the management
of COVID-19. The Lancet Haematology. 2020;7(5):e362-e3.